Nystop and Atrial fibrillation/flutter - a phase IV clinical study of FDA data

Summary:

Atrial fibrillation/flutter is reported as a side effect among people who take Nystop (nystatin), especially for people who are male, 60+ old, also take Metformin, and have Idiopathic pulmonary fibrosis.

The phase IV clinical study analyzes which people have Atrial fibrillation/flutter when taking Nystop. It is created by eHealthMe based on reports of 1,302 people who have side effects when taking Nystop from the FDA, and is updated regularly.

What is Nystop?

Nystop has active ingredients of nystatin. eHealthMe is studying from 1,310 Nystop users. Check the latest studies of Nystop.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,364 drugs and 3,841 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Jul, 07, 2026

1,302 people reported to have side effects when taking Nystop.
Among them, 17 people (1.31%) have Atrial fibrillation/flutter.

Could Nystop cause Atrial fibrillation/flutter?

Among these 17 people:

What is the gender of people who have Atrial fibrillation/flutter when taking Nystop? *

female: 29.41 %
male: 70.59 %

What is the age of people who have Atrial fibrillation/flutter when taking Nystop? *

What are other drugs people take besides Nystop? *

What are other side effects people have besides Atrial fibrillation/flutter? *

Pneumonia: 9 people, 52.94%
Cardiac Failure Congestive: 9 people, 52.94%
Oxygen Saturation Decreased: 7 people, 41.18%
Fatigue (feeling of tiredness): 6 people, 35.29%
Diarrhea: 6 people, 35.29%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 5 people, 29.41%
Fainting (loss of consciousness and postural tone): 4 people, 23.53%
Diabetes Mellitus Inadequate Control: 4 people, 23.53%
Pleural Effusion (water on the lungs): 4 people, 23.53%
Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 23.53%

What are the existing conditions these people have? *

Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 23.53%
Immunodeficiency Common Variable: 3 people, 17.65%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 5.88%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.88%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 5.88%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 5.88%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 1 person, 5.88%
Multiple Myeloma (cancer of the plasma cells): 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Nystop and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nystop:

Nystop (1,310 reports)

Browse all side effects of Nystop:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (2,364 drugs)

Browse all the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,841 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nystatin (the active ingredients of Nystop) and Nystop (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.